Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Asia Partnership Conference Starts Talks for Early NDA Approval at Inauguration Meeting in Tokyo
March 19, 2012
- JMA “Totally Opposed” to Japan’s Participation in TPP
March 16, 2012
- JPMA Compiles Policies for Transparency in Patient Group Relationships, Disclosure for States of Donations
March 15, 2012
- Wholesale Industry FTC to “Watch Closely” How Drug Makers Respond to Tougher Rules on Business Entertaining
March 7, 2012
- KSLION to Stimulate Innovation in Life Science in Japan: Prof. Y. Natsumeda
March 5, 2012
- Generic Drug Share Reaches 23.6% in 3rd Quarter of FY2011: JGA
March 2, 2012
- EFPIA Japan Chairman Fauchet Says New Committee to Review Health Economic Assessment
March 1, 2012
- Daiichi-Sankyo, Eisai, Pfizer Japan Leaving Strongest Impression at Dispensing Pharmacies: NPhA Survey
February 29, 2012
- JPWA President Bessho Welcomes NPhA’s Efforts for Drug Distribution Improvement
February 29, 2012
- JPA Incumbent President Kodama Reelected as Next Term Candidate
February 28, 2012
- Sales by Member Companies Rose 5% in 2011: JCROA
February 28, 2012
- NPhA Refers Plan to Recommend Next President to Board Review
February 27, 2012
- Toshiki Iwasaki to Step Down as NPhA President in May
February 24, 2012
- JSCTR to Set Up“GCP Expert” Certification to Improve Quality of Clinical Studies
February 21, 2012
- Japan Pharmaceutical Political Association Chairman Kumakura to Focus on Resolving Price Difference
February 21, 2012
- Prof. Kimura of Saga Univ. Receives Top Award for Research on Ubiquilin 1 Inhibitor
February 17, 2012
- 12 Organizations from 11 Countries, Regions to Participate in Asian Cooperation Conference
February 16, 2012
- JPMA VP Nogimori Focused on Thorough Compliance, Promotion of International Cooperation
February 15, 2012
- KIF5B-RET Fusion Gene Identified as Potential Target in Pulmonary Adenocarcinoma
February 13, 2012
- NPhA Compiles Draft Proposal for Mutual Understanding to Improve Distribution
February 10, 2012
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…